294 related articles for article (PubMed ID: 28982208)
41. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
42. Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Is it Safe?
Menon A; Abraham AG; Mahfouz M; Thachuthara JJ; Usmani N; Warkentin H; Ghosh S; Nijjar T; Severin D; Tankel K; Paulson K; Mulder K; Roa W; Joseph K
Am J Clin Oncol; 2021 Sep; 44(9):487-494. PubMed ID: 34269694
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer.
Kim JS; Kim JS; Cho MJ; Yoon WH; Song KS
J Korean Med Sci; 2006 Feb; 21(1):52-7. PubMed ID: 16479065
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.
Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y
Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453
[TBL] [Abstract][Full Text] [Related]
45. The outcome of 5-fluorouracil chemotherapy after the completion of neoadjuvant chemoradiotherapy, administered until 2 weeks before rectal cancer resection.
Chang PK; Chiang MH; Jao SW; Wu CC; Lee CC; Lee TY; Hsiao CW
J Chin Med Assoc; 2015 Aug; 78(8):475-80. PubMed ID: 26144023
[TBL] [Abstract][Full Text] [Related]
46. [Research hotspot and progress of preoperative chemoradiotherapy for rectal cancer].
Peng J; Pan Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):612-7. PubMed ID: 27353093
[TBL] [Abstract][Full Text] [Related]
47. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).
Dewdney A; Cunningham D; Tabernero J; Capdevila J; Glimelius B; Cervantes A; Tait D; Brown G; Wotherspoon A; Gonzalez de Castro D; Chua YJ; Wong R; Barbachano Y; Oates J; Chau I
J Clin Oncol; 2012 May; 30(14):1620-7. PubMed ID: 22473163
[TBL] [Abstract][Full Text] [Related]
48. Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil.
Yerushalmi R; Idelevich E; Dror Y; Stemmer SM; Figer A; Sulkes A; Brenner B; Loven D; Dreznik Z; Nudelman I; Shani A; Fenig E
J Surg Oncol; 2006 Jun; 93(7):529-33. PubMed ID: 16705722
[TBL] [Abstract][Full Text] [Related]
49. Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer.
Paszt A; Ottlakan A; Abraham S; Simonka Z; Vas M; Maraz A; Szepes Z; Tiszlavicz L; Nyari T; Olah J; Lazar G
Pathol Oncol Res; 2022; 28():1610722. PubMed ID: 36567978
[No Abstract] [Full Text] [Related]
50. Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer: Does Time to Surgery Matter?
Panagiotopoulou IG; Parashar D; Qasem E; Mezher-Sikafi R; Parmar J; Wells AD; Bajwa FM; Menon M; Jephcott CR
Int Surg; 2015 Jun; 100(6):968-73. PubMed ID: 26414816
[TBL] [Abstract][Full Text] [Related]
51. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.
Sauer R; Liersch T; Merkel S; Fietkau R; Hohenberger W; Hess C; Becker H; Raab HR; Villanueva MT; Witzigmann H; Wittekind C; Beissbarth T; Rödel C
J Clin Oncol; 2012 Jun; 30(16):1926-33. PubMed ID: 22529255
[TBL] [Abstract][Full Text] [Related]
52. Intensified neoadjuvant chemoradiotherapy in locally advanced rectal cancer -- impact on long-term quality of life.
Kripp M; Wieneke J; Kienle P; Welzel G; Brade J; Horisberger K; Wenz F; Post S; Gencer D; Hofmann WK; Hofheinz RD
Eur J Surg Oncol; 2012 Jun; 38(6):472-7. PubMed ID: 22349986
[TBL] [Abstract][Full Text] [Related]
53. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
[TBL] [Abstract][Full Text] [Related]
54. Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study.
Kamiya T; Uehara K; Nakayama G; Ishigure K; Kobayashi S; Hiramatsu K; Nakayama H; Yamashita K; Sakamoto E; Tojima Y; Kawai S; Kodera Y; Nagino M;
Eur J Surg Oncol; 2016 Jun; 42(6):829-35. PubMed ID: 26968228
[TBL] [Abstract][Full Text] [Related]
55. Gene expression levels of gamma-glutamyl hydrolase in tumor tissues may be a useful biomarker for the proper use of S-1 and tegafur-uracil/leucovorin in preoperative chemoradiotherapy for patients with rectal cancer.
Sadahiro S; Suzuki T; Tanaka A; Okada K; Saito G; Miyakita H; Ogimi T; Nagase H
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1077-1085. PubMed ID: 28417167
[TBL] [Abstract][Full Text] [Related]
56. [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].
Cao WG; Zhao R; Xi WQ; Ma T; Li H; Xu HP; Che JF; Jin YN
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):225-7. PubMed ID: 17649643
[TBL] [Abstract][Full Text] [Related]
57. Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer.
Ben-Josef E
Am J Clin Oncol; 2007 Dec; 30(6):649-55. PubMed ID: 18091061
[TBL] [Abstract][Full Text] [Related]
58. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
59. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.
Mohiuddin M; Regine WF; John WJ; Hagihara PF; McGrath PC; Kenady DE; Marks G
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):883-8. PubMed ID: 10705009
[TBL] [Abstract][Full Text] [Related]
60. Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer.
Wong SJ; Moughan J; Meropol NJ; Anne PR; Kachnic LA; Rashid A; Watson JC; Mitchell EP; Pollock J; Lee RJ; Haddock M; Erickson BA; Willett CG
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):116-23. PubMed ID: 25446610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]